Dendreon Corp (NASDAQ:DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Recs

1
Player Avatar UgolinoII (76.25) Submitted: 8/5/2011 6:45:32 AM : Outperform Start Price: $12.61 DNDN Score: -52.11

for the bounce

Report this Post Reply

Featured Broker Partners


Advertisement